Insmed (INSM)

Insmed (INSM) Financial Statements


Insmed Financial Overview

Insmed's market cap is currently ―. The company's EPS TTM is $-5.27; its P/E ratio is -5.03; Insmed is scheduled to report earnings on February 23, 2024, and the estimated EPS forecast is $-1.17. See an overview of income statement, balance sheet, and cash flow financials.
Sep 23Jun 23Mar 23Dec 22Sep 22
Income Statement-
Total Revenue$ 79.07M$ 77.23M$ 65.21M$ 59.30M$ 67.73M
Gross Profit$ 62.37M$ 60.63M$ 51.38M$ 46.23M$ 54.26M
EBIT$ -138.10M$ -223.66M$ -139.28M$ -143.55M$ -127.42M
EBITDA$ -132.83M$ -218.40M$ -134.37M$ -142.29M$ -125.31M
Net Income Common Stockholders$ -158.93M$ -244.81M$ -159.78M$ -160.08M$ -131.15M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 785.94M$ 917.79M$ 998.67M$ 1.15B$ 513.29M
Total Assets$ 1.32B$ 1.44B$ 1.52B$ 1.66B$ 994.82M
Total Debt$ 1.20B$ 1.19B$ 1.18B$ 1.18B$ 829.77M
Net Debt$ 411.26M$ 269.86M$ 186.04M$ 29.62M$ 316.48M
Total Liabilities$ 1.61B$ 1.59B$ 1.56B$ 1.66B$ 1.02B
Stockholders Equity$ -289.36M$ -155.75M$ -44.65M$ 87.95M$ -29.96M
Cash Flow-
Free Cash Flow$ -238.91M$ -137.22M$ -140.16M$ -106.04M$ -90.41M
Operating Cash Flow$ -236.06M$ -132.34M$ -136.76M$ -101.35M$ -89.83M
Investing Cash Flow$ 20.14M$ -264.66M$ 32.10M$ 18.52M$ 49.42M
Financing Cash Flow$ 1.25M$ 44.33M$ -399.00K$ 743.39M$ 37.12M
Currency in USD

Insmed Earnings and Revenue History

Insmed Debt to Assets

Insmed Cash Flow

Insmed Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis